Wynn Capital’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$278K Hold
240
– – 0.12% 105
2026
Q2
$288K Buy
240
+10
+4% +$10.2K 0.13% 99
2026
Q1
$212K Buy
230
+35
+18% +$35.5K 0.11% 105
2025
Q4
$210K Buy
+195
New +$186K 0.1% 107

Other funds holding LLY

Wynn Capital's LLY Position: Q3 2026 in Review

Wynn Capital held its Eli Lilly (LLY) position steady in Q3 2026 at 240 shares worth $278K. The position accounts for 0.12% of the portfolio, ranked #105.

Wynn Capital first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. The position peaked at $288K in Q2 2026. 278 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Wynn Capital held 240 shares of Eli Lilly worth $278K as of Q3 2026.
  • Wynn Capital left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 0.12% of Wynn Capital's portfolio in Q3 2026, its #105 holding.
  • Wynn Capital first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • Wynn Capital's Eli Lilly position peaked at $288K in Q2 2026.
  • 278 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Wynn Capital's 13F filing for Q3 2026, filed 13 Oct 2026.